Damien Webb
5Patents
1h-index
15Co-inventors
40Inventor score
Filing activity: Jul 28, 2016 → Oct 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9845301B2 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10428034B2 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10723711B2 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11524954B2 | Piperazine azaspiro derivatives | Chemistry; Metallurgy | 0 | Active |
| US12398119B2 | Piperazine azaspiro derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.